Literature DB >> 11750106

Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.

G H Danet1, H W Lee, J L Luongo, M C Simon, D A Bonnet.   

Abstract

OBJECTIVE: The relationship between phenotype and function in ex vivo-cultured human hematopoietic stem cells (HSC) remains poorly understood. We investigated the effects of a short-term serum-free culture on the relationship between stem cell phenotype, cell division history, and function in human CD34(+) cells.
METHODS: G-CSF-mobilized peripheral CD34(+) cells were cultured for 4 days with stem cell factor, flt-3 ligand, and thrombopoietin. The phenotype (CD34, CD38, HLA-DR, c-kit), cell division history, colony-forming cell (CFC), long-term culture-initiating cell (LTC-IC), and NOD/SCID repopulating activities were evaluated at Day 0 and 4.
RESULTS: We observed a loss of CD38, HLA-DR, and c-kit surface expression resulting in a drastic increase in CD34(+)CD38(-), CD34(+)HLA-DR(-), and CD34(+)c-kit(-/low) cells at Day 4. In contrast, the frequency of Thy-1(+) cells was maintained. We observed a 1.3-fold expansion of CFC, a 4.8-fold increase in LTC-IC, and an overall maintenance of the NOD/SCID repopulating cell activity. CD34(+)CD38(-) and CD34(+)HLA-DR(-) cells detected at Day 4 displayed the most active pattern of division (4 to 5 divisions) whereas 60% of CD34(+)Thy-1(+) cells divided 0 to 2 times during the same period. At Day 4, the NOD/SCID repopulating activity was associated with Thy-1(+) cells with no more than 2 divisions.
CONCLUSIONS: Our results show that the relationship between stem cell phenotype and function is dramatically altered in cultured CD34(+) cells. Thy-1 expression and cell division history appear to be superior to CD38, HLA-DR, and c-kit, or to homing molecules (CXCR4, VLA-4) as predictors of the repopulating activity of cultured peripheral CD34(+) cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750106     DOI: 10.1016/s0301-472x(01)00750-0

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  18 in total

1.  Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.

Authors:  Santosh Saraf; Hiroto Araki; Benjamin Petro; Youngmin Park; Simona Taioli; Kazumi G Yoshinaga; Emre Koca; Damiano Rondelli; Nadim Mahmud
Journal:  Transfusion       Date:  2014-11-02       Impact factor: 3.157

2.  Osteoblast lineage cells expressing high levels of Runx2 enhance hematopoietic progenitor cell proliferation and function.

Authors:  Brahmananda R Chitteti; Ying-Hua Cheng; Drew A Streicher; Sonia Rodriguez-Rodriguez; Nadia Carlesso; Edward F Srour; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

3.  Hematopoietic stem cells in research and clinical applications: The "CD34 issue".

Authors:  Zoran Ivanovic
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

4.  Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts.

Authors:  K Mizrahi; I Yaniv; S Ash; J Stein; N Askenasy
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

5.  Hierarchical organization of osteoblasts reveals the significant role of CD166 in hematopoietic stem cell maintenance and function.

Authors:  Brahmananda R Chitteti; Ying-Hua Cheng; Melissa A Kacena; Edward F Srour
Journal:  Bone       Date:  2013-01-28       Impact factor: 4.398

6.  Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.

Authors:  Peter Ebeling; P Bach; U Sorg; A Schneider; T Trarbach; D Dilloo; H Hanenberg; S Niesert; S Seeber; T Moritz; M Flasshove
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-20       Impact factor: 4.553

7.  Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach.

Authors:  Julie Lang; Nicholas Weiss; Brian M Freed; Raul M Torres; Roberta Pelanda
Journal:  Clin Immunol       Date:  2011-04-14       Impact factor: 3.969

8.  Expansion of human SCID-repopulating cells under hypoxic conditions.

Authors:  Guénahel H Danet; Yi Pan; Jennifer L Luongo; Dominique A Bonnet; M Celeste Simon
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Expansion of cord blood CD34 cells in presence of zVADfmk and zLLYfmk improved their in vitro functionality and in vivo engraftment in NOD/SCID mouse.

Authors:  Sangeetha V M; V M Sangeetha; Vaijayanti P Kale; Lalita S Limaye
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

10.  CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche.

Authors:  Brahmananda Reddy Chitteti; Michihiro Kobayashi; Yinghua Cheng; Huajia Zhang; Bradley A Poteat; Hal E Broxmeyer; Louis M Pelus; Helmut Hanenberg; Amy Zollman; Malgorzata M Kamocka; Nadia Carlesso; Angelo A Cardoso; Melissa A Kacena; Edward F Srour
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.